Yet Another Study Confirms Yaz Increases Risk of blood clots

(PRWEB) 9 November 2011 The Canadian Medical Association Journal published a study of 330,000 Israeli women indicating that blood clots more likely f...


(PRWEB) 9 November 2011

The Canadian Medical Association Journal published a study of 330,000 Israeli women indicating that blood clots more likely for those who suffer from Yaz and Yasmin, were the birth control pills that are included are synthetic hormone drospirenone, says attorney David Ennis.

in this study were 359 cases of deep vein thrombosis and 159 cases of pulmonary embolism. The risk of blood clots was 65 percent higher than in drospirenone users than in women. Second-generation contraceptives containing levonorgestrel and norgestrel, and 43 percent higher than women on third-generation pills containing desogestrel, gestodene and norgestimate

The risk was highest in the first four months of use. Other risk factors include high cholesterol, high blood pressure, cancer, obesity and older age.

venous thromboembolism (VTE) occurs when a blood clot forms in the veins of the legs or pelvis. Blood clots can break off and travel through the bloodstream to the lungs, causing a pulmonary embolism, can be fatal.

can

Jennifer Wu, MD, of Lenox Hill Hospital in New York, led the study and commented, I would probably avoid the ones (birth control], which contain drospirenone, just because the risk of blood clots in the lungs and legs.

This is the third study, published in the last two weeks to confirm the associated elevated dangerous risks with drospirenone-containing birth control pills such as Yaz and Yasmin. On 25 October 2011 The British Medical Journal published a study confirmed the same results, and on 27 October 2011, the U.S. Food and Drug Administration (FDA) published their independent study results confirm the significantly increased risk associated with drospirenone.? FDA advisers will meet 8 December to further review the safety of drospirenone-containing contraceptives.

Attorney David Ennis recommends that women who have made and experienced drospirenone-containing birth control pills any of these symptoms you should first immediately consult with their physician. Next, the patient should fill out a MedWatch Form at http://www.fda.gov. Finally, the patient should the opinion of an experienced lawyer to explore their rights.

Ennis & P.A. offering free nationwide confidential consultations for patients who have taken drospirenone-containing drugs or under and suffer these symptoms by calling toll-free 1-800-856-6405 or by going to http://www.ennislaw.com and completing an online case evaluation form.

Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington DC Ennis & Ennis, PA concentrates its practice in mass torts clause and represents individuals against pharmaceutical companies and medical device manufacturers.

Ennis & Ennis, P.A. has been representing clients individually since 1986 and has recovered over $ 100 million in settlements for its clients.

Ennis & Ennis, P.A. also investigated cases, Accutane, Actos, Avandia, Fosamax, Paxil, Zoloft, Prozac, DePuy Hip Recall, Hip Recall room, Depakote, Reglan, SJS / Dilantin, Yaz, Yasmin, Ocella Birth Control Pills and Transvaginal Mesh Devices.


Remember

the law limits the time in which you can file a claim, so do not wait to explore your legal rights. Call toll-free 1-800-856-6405 today or visit http://www.ennislaw.com.

# # #

clear = “all”

Leave a Reply